Prof. St?ckle現(xiàn)任柏林夏洛特大學綜合醫(yī)院肌肉骨骼外科中心行政院長和大主任、他也是AO Trauma德國區(qū)主席。從2019年起,柏林夏洛特大學綜合醫(yī)院連續(xù)3年被美國《新聞周刊》評選為歐洲排名第一的綜合醫(yī)院,Prof. St?ckle領導的柏林夏洛特大學醫(yī)院肌肉骨骼外科中心也在美國《新聞周刊》最佳骨科榜單連續(xù)兩年被評選為全球第三。在2004年以前的德國,骨科與創(chuàng)傷外科是兩個獨立的學科。在中國大多數(shù)醫(yī)院,骨科是大科,而創(chuàng)傷外科是隸屬骨科的一個亞專科。早在2003年,Prof. St?ckle與同事們敏銳地察覺到這兩個學科日常工作的重合以及合并后可能帶來的協(xié)同效應,他們進行了學科改革,建立了全德國第一個肌肉骨骼外科中心。作為AO Trauma德國區(qū)主席,他鼓勵同行積極參與國際學術研討,推動學科發(fā)展、提高臨床水平。2022年Prof. St?ckle在中國武漢、貴陽、佛山、重慶四家三甲醫(yī)院接收了四位臨床醫(yī)學MD博士。上周四下午St?ckle教授專門與仁醫(yī)醫(yī)療國際公共關系部門負責創(chuàng)傷、關節(jié)、運動醫(yī)學的同事們一同召開了一場全英文閉門會議,討論四位中國臨床醫(yī)學博士生的項目進展和細節(jié)。目前所有中國醫(yī)生已拿到了導師的邀請函,并提交了學歷認證,正在等待大學博士委員會的審核,通過后可拿到大學臨床醫(yī)學博士的錄取通知書。他們學成歸國將回到自已所在的城市和醫(yī)院,他們中的每一位醫(yī)生都將在各自領域成為具有“全球思考”思維模式的學科帶頭人和新生代醫(yī)生,為中國醫(yī)療事業(yè)發(fā)光發(fā)熱,添磚加瓦。
Prof. St?ckle is the Managing Director of the Center for Musculoskeletal Surgery (CMSC) of Charité - Universit?tsmedizin Berlin and the President of AO Trauma Germany. Since 2019, Charité has been ranked as the best hospital in Europe by the U.S. Newsweek for consecutive three years. And the CMSC led by Prof. St?ckle has been ranked among the TOP 3 orthopedics-specialized hospitals by the U.S. Newsweek for consecutive 2 years. In Germany, Trauma Surgery and Orthopedics used to be two independent fields before 2004. Whereas in most hospitals in China, Trauma Surgery is still a sub-specialty of Orthopedics. As early as 2003, the team at Charité had been keenly aware of the overlap of, the daily work of the two fields and the potential synergy resulting from merger. They then get started reforming and later established the first Center for Musculoskeletal Surgery in Germany. As the President of AO Trauma Germany, he calls for active engagement in international exchanges, to further develop the field and the individual clinical expertise of the colleagues. In 2022, Prof. St?ckle decided to accept four M.D. doctoral students from hospitals respectively in Wuhan, Guiyang, Foshan and Chongqing in China. Last Thursday afternoon, Prof. St?ckle held an internal meeting with the PR team at Gloryren. Discussing the progress and details of the four mentioned M.D. programs. All applicants have received the invitation letter and submitted an application for eligibility check, and are now waiting for the approval from the doctoral committee, after which they will received admission letters from the university. They will return to their affiliation in China after getting the degree. Each of them will become key-opinion leader and new-generation surgeon, with global-thinking mindset in their own field, making important contributions to the healthcare in China.